Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation

Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Feb 3, 2025

Keywords

ClinConnect Summary

This clinical trial is looking to better understand cardiomyopathy, a condition that affects the heart muscle and can lead to heart failure or the need for a heart transplant. Researchers want to find new ways to diagnose and predict how these conditions will progress by studying specific markers in the blood called microRNAs and other advanced techniques. The goal is to improve how doctors manage patients with various types of cardiomyopathy, including hypertrophic cardiomyopathy and dilated cardiomyopathy.

If you or someone you know has been diagnosed with cardiomyopathy and is at least 12 years old, you might be eligible to participate in this study. Participants will undergo several tests, including heart imaging and genetic testing, to help researchers gather important information. There are no major exclusions for joining, and the study aims to discover new ways to identify and monitor these heart conditions more effectively. This could ultimately lead to better care and treatment options for patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients diagnosed with CMP according to current international guidelines
• • Age ≥ 12 years at the time of diagnosis
• • Obtaining informed consent from the patient and the parent or legal guardian (in the case of patients aged \< 18 years)
• Exclusion Criteria:
• • none